Diagnostic performance and interchangeability of two commercial anti-RSV−IgG and IgA ELISAs across clinically relevant populations
Rainer Gosert, Svenia Schmid, Laura Infanti, Andreas Holbro, Andreas Buser, Jakob Passweg, Jörg Halter, Jonas Lötscher, Carla S. Walti, Sarah Tschudin-Sutter, Nina Khanna, Ulrich Heininger, Karoline Leuzinger · 2026
Read Diagnostic performance and interchangeability of two commercial anti-RSV−IgG and IgA ELISAs across clinically relevant populations by Rainer Gosert, Svenia Schmid, Laura Infanti, Andreas Holbro, Andreas Buser, Jakob Passweg, Jörg Halter, Jonas Lötscher, Carla S. Walti, Sarah Tschudin-Sutter, Nina Khanna, Ulrich Heininger, Karoline Leuzinger (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13435726.txt.
Description
Rainer Gosert and a large team compare two shop bought antibody tests for RSV in 2026. Blood from 462 people spans healthy adults, pregnant women, children, and transplant patients with vaccine shots. Both kits hunt total IgG and IgA against the virus.
Agreement on IgG calls ran high at 83.8 percent. One kit still read higher values and more positives across the board. Both kits tracked the sharper pre fusion antibody well, most in children. IgA showed rarely and matched less well. The kits are not swaps for each other, the team warns. Clinics must stick with one kit when tracking change.
Catalog record
| CREATOR | Rainer Gosert, Svenia Schmid, Laura Infanti, Andreas Holbro, Andreas Buser, Jakob Passweg, Jörg Halter, Jonas Lötscher, Carla S. Walti, Sarah Tschudin-Sutter, Nina Khanna, Ulrich Heininger, Karoline Leuzinger |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34192 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |